LBO — ST. MARY MEDICAL CENTER INC.
IRR: 17.6% | MOIC: 2.25x
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
17.6%
IRR
2.25x
MOIC
$313.1M
Entry EV
$490.3M
Exit EV
$161.1M
Equity Invested
Sources & Uses
S&UTotal · $313.1M| Item | Amount | % | Distribution |
|---|---|---|---|
| Senior Debt | $121.6M | 38.8% | |
| Sub Debt | $30.4M | 9.7% | |
| Equity | $161.1M | 51.5% | |
| Enterprise Value | $304.0M | 97.1% | |
| Transaction Fees | $9.1M | 2.9% | |
| Total Uses | $313.1M | 100.0% |
Interpretation
INTAt 2.25x MOIC and 17.6% IRR over 5 years, this deal meets the 15-20% range — acceptable with operational upside.
Key drivers: Check the EBITDA bridge to identify highest-probability levers, the debt schedule for leverage trajectory, or the challenge solver to see what breaks the deal.
Returns Waterfall
WFL| Component | Value |
|---|---|
| Exit Ebitda | $46.7M |
| Exit Ev | $490.3M |
| Net Debt At Exit | $127.9M |
| Equity At Exit | $362.4M |
| Equity Invested | $161.1M |
| Total Value Created | $201.3M |
| Value From Growth | $171.1M |
| Value From Multiple | $15.2M |
| Value From Deleveraging | $24.1M |